Sumanr In human cervical neoplasia human papillomaVirus (HPV) type 18 has a higher cancer cervical intraepithelial neoplasia (CIN) prevalence ratio than HPV 16. Fibrosarcomas derived from rat fibroblasts transfected with HPV 16 or 18 genomes showed increased apoptosis compared with controls. However. HPV 18 was associated with significantlx less apoptosis than HPV 16. affording one possible explanation for the more rapidly progressive cervical neoplasia associated with HPV 18.
There is strong evidence for a contribution by human papillomaviruses (HPVs) to the development of cervical intraepithelial neoplasia (CIN) lesions and cerVical cancer. but the precise mechanisms are still controversial (Arends et al.. 1990: zur Hausen. 1994) . Clinical and experimental data point to an association of the tw o common high-risk genital types. HPV 16 and 18. with formation of high-grade premalignant lesions (CIN 2 and 3) (Gissmann. 1984 : de Villiers et al.. 1987 . 1993a : Lorincz et al.. 1992 : Schiffman et al.. 1993 . The largest increase in prevalence of HPV 16 and 18 in the spectrum of cervical neoplasia occurs between CIN I and CIN 2 3 (Arends et al.. . 1993a Lorincz et al.. 1992) . and these types max% be found in up to 90°0 of cervical cancers (Xiao et al.. 1988 : StanleN-. 1990 : Schiffman et al.. 1993 . In contrast. the low-risk types. HPV 6b. 11 and others. are most frequentlx found in genital warts and CIN 1 (Pater et al.. 1986 : de Villiers et al.. 1987 : Schiffman et al.. 1991 
Materials and methods
The parent cell line was the Fischer rat lung fibroblast 208F (Quade. 1979) . and transfectants were derived from it as previously described (Arends et al.. 1993b . bearing (1) HPV genomes of types 16 or 18 (Storey et al.. 1988) . without (H16 and H18) or with (H16R and H18R) the plasmid pHO5Tl (Spandidos and Wilkie. 1984) that expressed the human T24-Ha-ras-1 oncogene with a point mutation at codon 12: (2) only the T24-ras expression vector pHOSTl (Ti) (Spandidos and Wilkie. 1984): and (3) only the c-mv c expression plasmid pHRMCGMI (M8) (Arends et al.. 1993b ). Approximately 10 million cells were injected subcutaneously into the groins of between 6 and 11 immunosuppressed CBA mice. prepared as previously described (Wyllie et al.. 1987 ). for each cell line. Animals were subjected to autopsy after 12 days. All analytical techniques were as described prev-iously- (Arends et al.. 1993b ). In brief. the size of tumours growing at the injection site was measured in three dimensions in millimetres. and these were multiplied together to giv e a nominal 'box volume' convenient for comparisons. Representative equatorial blocks of tumour were fixed in formalin. processed and stained with haematoxylin and eosin. The number of mitotic and apoptotic figures were counted per ten high-power fields. for at least six tumours formed by each cell line. Tumour necrosis was assessed on a four-point scale. The raw data for mitotic counts and apoptotic counts were combined to form ratios of apoptosis mitosis (A M) in an attempt to correct for bias introduced into these counts through differences in cell size and packinz density. (Figure 1 ). The only significant differences in mitotic counts were between H16 and either H18 or H18R (P<0.0005 for both comparisons) and these were relatively small compared to the differences in apoptotic counts.
All transfectants generated tumours which were larger in size than the static or regressing nodules formed by the parent cell line 208F (Figure 1 ). Tumours formed by H18 were larger than those formed by H16. However, H16R tumours were similar in size to those formed by H18R, both of which showed marked central necrosis. Student's t-tests showed significant differences in tumour size between 208F and the transfectants H16R (P<0.0001), H18 (P=0.035), and TI (P<0.0001); and also between H16 and H16R (P= 0.0037).
Companrsons of cell turnover parameters with tumour sizes for the four HPV-containing transfectants (H16, H18, H16R and H18R) showed that apoptotic counts inversely correlated with tumour sizes (r =-0.79), whereas mitotic counts positively correlated with tumour sizes (r = 0.85). The A/M ratios also correlated inversely with tumour sizes (r = -0.87). Overall, for all seven cell lines, including 208F, M8 and TI, log A/M ratios showed an inverse correlation with tumour sizes (r =-0.81; regression equation log A/M = 1.16-1.55 x size; P = 0.029) and with log tumour sizes (r =-0.93; regression equation log A/M =-0.805-1.31 x log size; P = 0.002). The two common high-nrsk genital HPV types were associated with moderate to high levels of tumour cell apoptosis. similar in degree to that stimulated by c-myc, previously shown to be a potent inducer of apoptosis (Wyllie et al.. 1987; Evan et al., 1992; Arends et al.. 1993b . HPV 18 was associated with lower levels of tumour apoptosis than HPV 16. and this pattern was not modulated by the presence of T24-ras. The sizes of tumours correlated inversely with both the absolute levels of apoptosis and the ratios of apoptosis,mitosis. Thus, the intrinsic rate of apoptosis within tumours is differentially modulated by HPV type and appears to be a major regulator of net growth rate. Possible mechanisms by which HPV 16 and 18 E7 proteins may stimulate apoptosis include the binding and inactivation of Rb protein (Phelps et al.. 1988; Munger et al., 1989 Munger et al., , 1991 (Howes et al.. 1994; Pan and Griep, 1994) .
HPV 16 and 18 E6 products have apoptosis-suppressing effects, as they both bind p53 and direct its rapid degradation (Werness et al., 1990; Scheffner et al.. 1991) . Wild-type p53 (but not mutant p53) has been shown to induce apoptosis in myeloid, lymphoid and epithelial cells (Yonish-Rouach et al., 1991; Shaw et al., 1992; Clarke et al., 1993 Clarke et al., , 1994 , and studies in both fibroblast cell lines and transgenic mice have suggested that E6 can block the apoptosis-inducing function of p53 in the presence of HPV E7 (Howes et al., 1994; Pan and Griep, 1994; White et al.. 1994) . Thus, the two HPV transforming genes have opposing effects on apoptosis: stimulation via HPV E7-mediated inactivation of Rb with activation of both mvc and E2F-I and inhibition via HPV E6-mediated degradation of wild-type p53. The relative strengths of these activities will be affected by the comparative levels of expression of E7 and E6, and their relative (H16, H16R, H18, H18R ) and a T24-ras transfectant (TI). The means ( ± s.e.m. as error bars) of mitotic and apoptotic counts per ten high-power fields for six tumours are shown, along with tumour sizes in cm3.
. Mitosis; . apoptosis; M. size. efficiencies in terms of protein function and stability. One speculative explanation for the lower levels of apoptosis associated with HPV 18 is that there may be saturation of the pro-apoptotic E7-Rb-E2F-myc pathway by both HPV types (both show increases in apoptosis above control levels that are similar to mic-induced levels), but higher activity of the anti-apoptotic E6-p53 pathway associated with HPV 18 owing to greater concentrations of HPV 18 E6 (compared with HPV 16 E6), because of the more efficient upstream regulatory region of HPV 18 producing higher levels of expression of the E6 gene (Barbosa and Schlegel. 1989: Romanczuk et al.. 1991 in this fibroblast system also occurred in cervical keratinocytes in CIN lesions in vivo. this would result in more rapid production of CIN cells, increasing the probability of further genetic changes required for transition to malignancy, such as integration of the HPV genome, activation of cellular oncogenes or loss of oncosuppressor genes. Furthermore. selection pressures may be different, in that reduced apoptosis due to greater inactivation of p53 by HPV 18 E6 may allow survival of DNA-damaged cells that would otherwise die by p53-induced apoptosis after genotoxic injury.
